Cardiac Resynchronisation Therapy (CRT) Survey II: CRT implantation in Europe and in Switzerland

Abstract

Compared with European CRT recipients, Swiss CRT patients are older, less symptomatic and suffer more often from comorbidities. Although two thirds of the implantations were CRT-defibrillator systems, Swiss patients more often received CRT-pacemaker systems than their European counterparts.

Adherence to ESC cardiac resynchronization therapy guidelines: findings from the ESC CRT Survey II

“…Of the countries participating in CRT Survey II eleven have published national publications benchmarking their countries data against the total cohort. [48][49][50][51][52][53][54][55][56][57][58] Overall, patient selection and guideline adherence was similar in the 42 participating countries. However, these publications have highlighted some interesting differences.…”

“…Croatia, Bulgaria, Poland, Switzerland and Germany all reported higher co-morbidities in their CRT population compared with the total cohort. 52,[54][55][56][57] Possible explanations for the higher rate of comorbidities in patients in Germany is speculated to be a reluctance in other European countries to implant CRT in 'sicker' patients. In Bulgaria patients also appear to be referred later for a CRT device as more patients were in NYHA Class III or IV.…”

“…52 Bulgaria, Croatia and Switzerland had lower percentage CRT-D than the total cohort. 52,55,57 The Croatian and Bulgarian implanters attribute this lower percentage to budgetary restriction; in Bulgaria CRT-D is not fully reimbursed and patients are not always able to afford co-payments for these devices. Switzerland, on the other hand, has a reimbursement system that allows for easy access to available technology.…”

Clinical and demographic characteristics of patients with congestive heart failure and implanted devices for cardiac resynchronization therapy

“…табл. 2, 3) [1,2,9,10,[12][13][14]25]. Это согласуется с данными о прогрессирующем возрастании участия постоянной формы ФП в развитии ХСН [26].…”

“…Всем пациентам, имеющим тахиформу ФП (n = 57), после имплантации устройств для СРТ была проведена радиочастотная абляция атриовентрикулярного соединения; пациенты с нормои брадиформой ФП получали соответствующую медикаментозную терапию. БЛНПГ у наших пациентов встречалась реже по сравнению с данными зарубежных регистров [1,2,6,10,11,25]; также у наших больных отмечалось меньшее исходное значение ширины комплекса QRS (см. табл.…”